HL-003

N/A

Report date: 2025/01/14 20:00:08
NME

Base Information

Drug NameHL-003
Drug Alias NameHL-003HL003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase 4 modulatorsSuperoxide dismutase [Mn], mitochondrial modulatorsTumor protein p53 inhibitors +[4] 
TargetsNADPH oxidase 4Superoxide dismutase [Mn], mitochondrialTumor protein p53 +[4] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Kezhou Pharmaceutical Co., Ltd.
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Kezhou Pharmaceutical Co., Ltd.
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A